SARCORSICA: SARC-F Questionnaire as a Screening Tool for Age-related Sarcopenia
SARCORSICA
Evaluation of the SARC-F Questionnaire, a New Screening Tool for Sarcopenia in People 65-year Old and Older in the Community
1 other identifier
interventional
366
1 country
2
Brief Summary
Background to the research: Sarcopenia is a geriatric syndrome defined by progressive generalised loss of skeletal muscle, mass, force and function. Problem statement and objectives: To validate a simple, reproducible, screening tool, which is easy to use in the general practitioner's surgery is one of the challenges of the future. The primary objective is to assess the sensitivity and specificity of the study screening test, the SARC-F, at a predetermined threshold of \>= 4. A total score of \>=4 is associated with poor physical performance and is also predictive of the clinical diagnosis of the disease. The secondary objectives are to assess the prevalence of sarcopenia in the study population, to carry out a subgroup analysis of statistical performance for the five questions tested by the SARC-F, to identify the main risk factors associated with the disease and to propose an algorithm, positioning the SARC-F at the heart of a systematic screening process for the disease. Materials and methods: This is a diagnostic, cross-sectional study with a descriptive and analytical epidemiological component to analyse the secondary endpoints. It will be carried out in usual care over a period of 6 months in a homogeneous population of 65-year-old and older patients from the community consulting in primary care. The subjects will undergo the screening test (SARC-F questionnaire) and then the reference clinical assessment (gold standard) in succession. Expected results: To demonstrate the statistical tests that the SARC-F questionnaire is a simple tool, appropriate for early screening of sarcopenia in primary care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2014
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 16, 2014
CompletedFirst Submitted
Initial submission to the registry
April 1, 2015
CompletedFirst Posted
Study publicly available on registry
July 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2016
CompletedFebruary 19, 2018
February 1, 2018
1.6 years
April 1, 2015
February 15, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
questionnaire SARC-F
thirty minutes
Secondary Outcomes (1)
number of participant
thirty minutes
Study Arms (1)
SARC-F
OTHERscreening test for sarcopenia being studied, the SARC-F
Interventions
* Skeletal muscle mass, which will be estimated by calculating values for the mid-arm muscle circumference (MAMC) from brachial perimeter (BP) and triceps skinfold thickness (TSF). * Muscle force will be measured using a hydraulic dynamometer * Physical performance will be estimated from the subject's Gait speed using a 4 meter gait test (Gait speed 4-m)
Eligibility Criteria
You may qualify if:
- Men or women who are 65-year old or older consulting a general practitioner, regardless of initial reason for the consultation.
- Patients agreeing to take part in the study after clear, true and appropriate information has been provided, giving their signed consent and having been given by hand a patient information sheet.
You may not qualify if:
- Patients with cognitive disorders suffering from major incapacity making understanding the study or signing the informed consent impossible.
- Patients not affiliated to a Social Security system.
- Patients suffering from acute functional problems interfering with the tests being performed (incapacity, malformation of the arm, plaster or splint).
- Patients institutionalised in nursing homes or subacute care
- Patients who use a technical aid for walking, unless this aid is a walking stick
- Patients not being followed up in a general practitioner's surgery (absence of information required to carry out the analytical part)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Cabinet de Médecine Générale
Cozzano, Corsica, 20148, France
Cabinet de médecine générale
Peri, Corsica, 20167, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stéphane M SCHNEIDER
schneider.s@chu-nice.fr
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 1, 2015
First Posted
July 1, 2015
Study Start
November 16, 2014
Primary Completion
June 10, 2016
Study Completion
June 10, 2016
Last Updated
February 19, 2018
Record last verified: 2018-02